NPI registry status
Active
2026 NPPES data Hematology & Oncology Physician NPI 1215139027 MD, FACP
Verify on CMS → Binu Nair, MD, FACP
Hematology & Oncology Physician in Waxahachie, Texas.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 11,232 in Hematology & Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
1K
Medicare Part D claims · 324 beneficiaries · Hematology & Oncology Physician avg: 847
Generic prescribing
81%
generic claims · 19% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$666.52
14 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Binu Nair, MD, FACP filed 1,306 Medicare Part D claims in 2023 as a Hematology & Oncology Physician in Waxahachie, Texas, prescribing 81% generic.
- 1K
- Part D claims, 2023
- 81%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥79th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Binu Nair, MD, FACP
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1215139027), first enumerated 06/04/2007.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,306 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$666.52 in reported industry payments (14 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- State context
State board disciplinary context
Texas statewide board action statistics are published annually — these figures describe aggregate state activity, not Binu Nair, MD, FACP's individual license status. Verify directly with the state medical board.
Source: TMB annual report 2023
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1215139027 · Hematology & Oncology Physician
NPI-10 · ENUM-MID · TAX-MID · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1215139027
- ENUM-MID 2007
- TAX-MID 11K Hematology &
- RX-MID 1,306
- BOOK-LIGHT 618 in Texas
- PHOTO-ENUM Terence Friedlander · 2007
Binu Nair, MD, FACP's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
1,306 ≥ 79th percentile 79% of 1,370,886 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Binu Nair, MD, FACP practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Binu Nair, MD, FACP?
Quality data not reportedPrimary specialty
Hematology & Oncology Physician
Medicare Part D claims
1,306 54% vs specialty avg
Specialty distribution in Texas
How Hematology & Oncology Physician compares to other specialties among Texas providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology & Oncology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1215139027 |
|---|---|
| Specialty | Hematology & Oncology Physician |
| Credentials | MD, FACP |
| Gender | Male |
| NPI Issued | 06/04/2007 |
Hospital and facility affiliations
Facilities where Binu Nair, MD, FACP bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Healthtexas Provider Network
Waxahachie, TX
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Binu Nair, MD, FACP. Source: openpaymentsdata.cms.gov.
Total received
$667
Largest payer
Lilly USA, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - Texas TMB 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 - they are NOT specific to Binu Nair, MD, FACP. To verify Binu Nair, MD, FACP's current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
Binu Nair, MD, FACP - brand share 19.0%
Hematology & Oncology Physician average
19% brand-name claims vs 81% generic, on 1,306 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,306
Total Claims
$1.5M
Total Drug Cost
324
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,607
- Total Day Supply
- 74,534
- Brand vs Generic
- 19% brand / 81% generic
- Brand Drug Cost
- $1.3M
- Generic Drug Cost
- $143K
- Opioid Claims
- 14 (1.1% rate)
- Antibiotic Claims
- 17
Patient Demographics
- Average Patient Age
- 72.8 years
- Avg HCC Risk Score
- 2.13
- Gender Split
- 77% female / 23% male
- Age Distribution
- <65: 20, 65-74: 176, 75-84: 113, 85+: 15
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Binu Nair, MD, FACP prescribes most
Top Medicare Part D drugs by claim count, 2023
- Letrozole
Letrozole
311 claims
- Anastrozole
Anastrozole
158 claims
- Eliquis
Eliquis
130 claims
- Alendronate Sodium 63
Alendronate Sodium
63 claims
- Valacyclovir 57
Valacyclovir
57 claims
- Lidocaine-Prilocaine 49
Lidocaine-Prilocaine
49 claims
- Ondansetron Odt 36
Ondansetron Odt
36 claims
- Dexamethasone 34
Dexamethasone
34 claims
| Drug | Claims |
|---|---|
| Letrozole | 311 |
| Anastrozole | 158 |
| Eliquis Apixaban | 130 |
| Alendronate Sodium | 63 |
| Valacyclovir Valacyclovir Hcl | 57 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 49 |
| Ondansetron Odt Ondansetron | 36 |
| Dexamethasone | 34 |
| Levothyroxine Sodium | 23 |
| Olanzapine | 23 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Hematology & Oncology Physician Overview
How Binu Nair, MD, FACP fits within the Hematology & Oncology Physician landscape nationally.
11,232
Hematology & Oncology Physician Providers in US
54
States with Hematology & Oncology Physician
847
Avg Claims per Provider
Binu Nair, MD, FACP's 1,306 claims are above the specialty average of 847.
Nationwide Hematology & Oncology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Nair, both outside Texas so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2007)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Hematology & Oncology Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as Nair.
One of 618 Hematology & Oncology Physician providers enrolled in Texas, 5 are shown here.
Dr. Elham Abbasi-Hafshejani
M.D.
The Woodlands, TX
Dr. Muhammad Abid
M.D.
Lubbock, TX
Dr. Ambrose Aboud
MD
El Paso, TX
Dr. Joel Abramowitz
M.D., PHD
Houston, TX
Dr. John Adams
DO
Arlington, TX
Compare Hematology & Oncology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Binu Nair, MD, FACP's specialty? ▼
Binu Nair, MD, FACP specializes in Hematology & Oncology Physician and practices in Waxahachie, Texas. Credentials: MD, FACP.
How much does Binu Nair, MD, FACP prescribe under Medicare Part D? ▼
In 2023, Binu Nair, MD, FACP wrote 1,306 Medicare Part D claims totaling $1.5M in drug costs for 324 beneficiaries.
Where is Binu Nair, MD, FACP located? ▼
Binu Nair, MD, FACP is located at 2380 N INTERSTATE 35 EAST SERVICE RD, Waxahachie, TX, 75165. Phone: (469) 843-6000.
What is Binu Nair, MD, FACP's NPI number? ▼
Binu Nair, MD, FACP's National Provider Identifier (NPI) is 1215139027, issued on 06/04/2007.
Does Binu Nair, MD, FACP prescribe more brand-name or generic drugs? ▼
Binu Nair, MD, FACP's prescribing is 19% brand-name and 81% generic drugs by claim count, with $1.3M in brand drug costs.
Does Binu Nair, MD, FACP prescribe opioids? ▼
Yes, Binu Nair, MD, FACP had 14 opioid claims in 2023 with an opioid prescribing rate of 1.1%.
How many Hematology & Oncology Physician providers are there in the US? ▼
There are 11,232 Hematology & Oncology Physician providers across 54 states in the US. The average Hematology & Oncology Physician provider writes 847 Medicare Part D claims per year.
What drugs does Binu Nair, MD, FACP prescribe most often? ▼
Based on 2023 Medicare Part D data, Binu Nair, MD, FACP's most frequently prescribed drugs include Letrozole, Anastrozole, Eliquis. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Binu Nair, MD, FACP accept Medicare? ▼
Binu Nair, MD, FACP appears in CMS Medicare data with 1,306 Part D claims and 324 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Binu Nair, MD, FACP's credentials? ▼
Binu Nair, MD, FACP's NPI is 1215139027 with credentials MD, FACP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.